تجاوز إلى المحتوى الرئيسي
عنوان الدراسة الجهاز رقم البروتوكول الراعي الحالة موقع الدراسة
A Randomized Study of the Effect of Maintenance Therapy With Bevacizumab + Capecitabine Versus Bevacizumab Alone on Progression-free Survival in Patients With HER2-negative Metastatic Breast Cancer That Has Not Progressed During First-line Docetaxel Plus MO22223
Roche
منتهي King Abdulaziz Hospital and Oncology Center (Jeddah)
A Phase IIIb, Interventional, Multicentre, Multinational, Randomised, Open-label Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 vs. Day 6 in Women Between 36 and 42 Years of Age Undergoing A EMR200061_506
Merck Serono
منتهي King Abdulaziz University Hospital (Jeddah)
Multicentre, Randomised, Controlled, Open-label Study Comparing the Efficacy and Safety of Slow Repeated IV Infusions of 2 Doses of Doxorubicin Transdrug™ (DT) (20mg/m2 and 30mg/m2) to Those of Best Standard of Care (BSC) in Patients With Advanced Hepa BA2011/03/04
Onxeo
مكتمل King Abdulaziz University Hospital (Jeddah)
A phase II, multicenter, open label study of treatment escalation to ACVD (Adriamycin, Cyclophosphamide, Vinblastine and Dacarbazine) and Brentuximab-Vedotin in advanced-stage Hodgkin Lymphoma patients with a positive interim PET scan after 2 ABVD cyc RC16/150
KAIMRC
جاري King Abdulaziz Medical City NG (Riyadh)
A multicenter, multinational, prospective, observational study to describe the clinical outcomes in patients with Type 2 diabetes mellitus, treated with iGlarLixi fixed ratio combination (SOLIQUA®) before, during and after the period of Ramadan (SoliRam OBS16049
Sanofi
جاري University District Hospital (Jeddah)
Post-authorization safety study in patients with type 2 diabetes mellitus to assess the incidence of ketoacidosis, severe complications of urinary tract infection, volume depletion, and dehydration among patients treated with EMPAGLIFLOZIN or DPP-4 inhib 1245/149
Boehringer Ingelheim
جاري Armed Force Hospital (Al-Hada)
An open label, Phase IV, multicenter study to Assess the efficacy and safety of Elica-MTM Cream Containing Miconazole nitrate 2% w/w and Mometasone furoate 0.1% w/w) in Napkin Dermatitis with Inflamed Skin Conditions of Eczema or Dermatitis Caused by Inf ELICA-M001
Jamjoom Pharmaceuticals
جاري King Abdulaziz University Hospital (Jeddah)
An open label, Phase IV Multicentric Single Arm Study to Assess the Safety and Efficacy of BetazoleTM Cream Containing Betamethasone dipropionate (0.05% W/W) and Miconazole nitrate (2% W/W) in Subjects with Inflamed Skin Conditions of Eczema or Dermatiti BETA001
Jamjoom Pharmaceuticals
جاري King Abdulaziz University Hospital (Jeddah)
A multicenter, multinational, prospective, observational study to describe the clinical outcomes in patients with type 2 diabetes mellitus, treated with insulin glargine 300 U/mL (insulin glargine U300) before, during and after the period of Ramadan / OR OBS16040
Sanofi
جاري King Abdulaziz University Hospital (Jeddah)
CRAD001H2406- A long-term non-interventional observational study in Living Donor Liver Transplant Recipients (LDLTRs) with primary hepatocellular carcinoma (HCC) treated with Certican® / Zortress® (everolimus; EVR) plus reduced tacrolimus (rTAC) versus CRAD001H24
Novartis
جاري King Faisal Specialist Hospital and Research Center (Riyadh)
عرض 11 - 20 من 118